Asthma: Medical Equipment
The question
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 July 2025 to Question 65186 on Asthma: Medical Equipment, which pharmaceutical companies are registered as marketing authorisation holders for (a) dry powder inhalers containing (i) salbutamol and (ii) terbutaline and (b) pressurised metered dose inhalers containing salbutamol.
Answered by Karin Smyth
The following table shows the four market authorisation holders (MAH) for dry power inhalers (DPIs) containing salbutamol and terbutaline, along with the three MAHs for pressurised metered dose inhalers (pMDIs):
Pharmaceutical company | Inhaler type | Medicine |
Glaxo Wellcome UK Ltd | DPI | Salbutamol |
Orion Corp | DPI | Salbutamol |
Maylan Products Ltd | DPI | Salbutamol |
Astrazeneca UK Ltd Pharmacovigilance | DPI | Terbutaline |
Sandoz B.V. | pMDI | Salbutamol |
Kent Pharma UK Ltd | pMDI | Salbutamol |
Cipla (EU) Ltd | pMDI | Salbutamol |
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →